The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

PHST PJSC PHARMSTANDARD GDR (4 GDRS EACH REPR 1 ORD) (REG S)



Income Statement  ($ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
Revenue  974.43 1332.93 1663.52 1735.14 703.80
Operating Profit/(Loss)  291.37 345.29 407.49 480.40 233.78
Net Interest  0.59 0.94 1.11 3.85 7.37
Profit Before Tax  300.15 351.18 411.47 482.40 235.94
Profit After Tax  235.14 276.02 326.39 362.51 189.43
Discontinued Operations
Profit After Tax  0.00 0.00 0.00 0.00 0.00
PROFIT FOR THE PERIOD  235.14 276.02 326.39 362.51 189.43
Attributable to:
Minority Interests  -0.47 -1.63 -5.67 -3.49 -4.34
Equity Holders of Parent Company  234.68 274.39 320.72 359.03 185.09
 
Continuing EPS
Earnings per Share - Basic  620.96¢ 756.47¢ 906.36¢ 1036.77¢ 509.11¢
Earnings per Share - Diluted  620.96¢ 756.47¢ 906.36¢ 1036.77¢ 509.11¢
Earnings per Share - Adjusted  620.96¢ 756.47¢ 906.36¢ 1036.77¢ 509.11¢
Continuing and Discontinued EPS
Earnings per Share - Basic  620.96¢ 756.47¢ 906.36¢ 1036.77¢ 509.11¢
Earnings per Share - Diluted  620.96¢ 756.47¢ 906.36¢ 1036.77¢ 509.11¢
Earnings per Share - Adjusted  620.96¢ 756.47¢ 906.36¢ 1036.77¢ 509.11¢
 
Dividend per Share  0.00¢ 0.00¢ 0.00¢ 0.00¢ 0.00¢

Balance Sheet  ($ m) 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Assets
Non-Current Assets
Property, Plant & Equipment  110.19 129.40 199.97 209.50 134.94
Intangible Assets  219.47 209.93 263.46 97.39 53.31
Investment Properties  0.00 0.00 0.00 0.00 0.00
Investments  0.00 0.00 14.31 61.31 129.79
Other Financial Assets  0.00 0.00 0.00 0.00 0.00
Other Non-Current Assets  32.67 44.41 49.47 53.90 40.87
  362.32 383.73 527.21 422.10 358.92
Current Assets
Inventories  245.07 223.29 276.45 227.68 120.36
Trade & Other Receivables  429.20 480.09 512.45 750.56 339.20
Cash at Bank & in Hand  136.43 168.22 277.22 467.26 145.83
Current Asset Investments  120.86 107.69 146.42 44.20 108.22
Other Current Assets  0.00 0.00 0.18 0.00 0.00
  931.55 979.29 1212.71 1489.70 713.60
 
Total Assets  1293.88 1363.02 1739.92 1911.80 1072.52
 
Liabilities
Current Liabilities
Borrowings  -12.99 -22.92 -7.92 -221.37 -75.71
Other Current Liabilities  -377.26 -374.94 -418.79 -788.16 -287.96
  -390.25 -397.86 -426.71 -1009.53 -363.66
 
Net Current Assets  541.30 581.43 786.01 480.17 349.94
 
Non-Current Liabilities
Borrowings  0.00 0.00 0.00 0.00 0.00
Provisions  -21.08 -18.18 -25.64 -13.51 -10.36
Other Non-Current Liabilities  -0.37 -0.29 -2.91 -4.59 -1.58
  -21.45 -18.47 -28.55 -18.09 -11.94
 
Other Liabilities  n/a n/a n/a n/a n/a
Total Liabilities  -411.71 -416.33 -455.26 -1027.62 -375.60
 
Net Assets  882.17 946.69 1284.66 884.18 696.91
 
Capital & Reserves
Share Capital  1.24 1.18 1.24 1.15 0.65
Share Premium Account  0.00 0.00 0.00 0.00 0.00
Other Reserves  -0.01 0.72 -0.17 0.71 12.43
Retained Earnings  866.88 928.69 1229.50 838.35 655.74
Shareholders Funds  868.11 930.59 1230.58 840.21 668.81
 
Minority Interests/Other Equity  14.06 16.09 54.09 43.97 28.10
Total Equity  882.17 946.69 1284.66 884.18 696.91

Ratios - based on IFRS 31-Dec-10 31-Dec-11 31-Dec-12 31-Dec-13 31-Dec-14
Continuing Operations
PE Ratio - Adjusted  0.05 0.02 0.02 0.01 0.01
PEG - Adjusted  0.01 0.00 0.00 0.00 0.00
Earnings per Share Growth - Adjusted  4.04% 21.82% 19.81% 14.39% -50.89%
Dividend Cover  n/a n/a n/a n/a n/a
Revenue Per Share  2578.34¢ 3674.83¢ 4.70¢ 5010.50¢ 1935.85¢
Pre-Tax Profit per Share  794.20¢ 968.17¢ 1.16¢ 1393.00¢ 648.97¢
Operating Margin  29.89% 25.90% 24.50% 27.69% 33.22%
Return on Capital Employed  43.16% 45.27% 39.12% 47.59% 33.35%
 
Continuing & Discontinued Operations
Dividend Yield  0.00% 0.00% 0.00% 0.00% 0.00%
Dividend per Share Growth  n/a n/a n/a n/a n/a
Net Asset Value per Share (exc. Intangibles)  1716.31¢ 1362.06¢ 2794.88¢ 2043.18¢ 1628.61¢
Net Gearing  -14.22% -15.61% -21.88% -29.27% -10.48%

Data is provided by Morningstar


Market

Company Information
Updated Monthly
Company address Likhachevsky Drive, 5 b, Dolgoprudny, Moscow, 141701, Russian Federation
Company website http://www.pharmstd.com
Market cap(in millions)* £ 377.55
Listing/Admission to trading 11 May 2007
Trading service International Order Book
Market MAINMARKET
Listing category Standard GDRs
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
01-Jun-16
FTSE index -
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Pharmaceuticals
Country of share register US
Segment IOBE
MiFID Status Regulated Market
Exchange market size 5,000
SEDOL B1W4MH7
ISIN number US7171402065



PJSC PHARM S share fundamentals (PHST)